Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
克唑替尼治疗MET扩增或14号外显子缺失的肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)C1和C2子方案的结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1247
Coleman, Niamh; Wei, Zihan; Iafrate, A John; Zwiebel, James A; Sharon, Elad; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Williams, Travis; Croley, Jessica J; Onitilo, Adedayo A; Tricoli, James V; Cheng, Ju; Karlovich, Chris; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay; O'Dwyer, Peter J; Hong, David S; Chen, Alice P; Flaherty, Keith T